Stockreport

Aevi Genomic Medicine advancing mid-stage study of AEVI-001 in ADHD; shares up 2% [Seeking Alpha]

AEVI GENOMIC MEDICINE INC  (GNMX) 
Last aevi genomic medicine inc earnings: 11/14 08:01 am Check Earnings Report
US:NASDAQ Investor Relations: aevigenomics.com
PDF Aevi Genomic Medicine advancing mid-stage study of AEVI-001 in ADHD; shares up 2% [Read more]